Recently, the opening ceremony of the Radioisotope laboratory of Norroy bioscience Co., Ltd. was officially held in Wuxi. Mr. Wu Yuding, founder of Xinghua Dingli, Zhuhai Bailui and other shareholders, Mr. Fang Peng, Chairman of Norroy, CEO Mr. Yan Chenglong, VP Mr. Yu Shenyou, CTO Dr. Wai-si Eng, and COO Dr. Wang Meng attended the ceremony and cut the ribbon, and then visited the site to witness Norroy stepping into a new stage of development.
Previously, Norroy had successfully obtained a radiation safety permit approved by Jiangsu Province. The official launch of the laboratory marks the quality upgrade of Norroy hardware facilities again, which not only provides sufficient guarantee for the innovative research and development and achievement transformation of innovative drugs and nuclear drug automation equipment, but also opens a new chapter in the future to enter the global market.
Norroy’s radioisotope workplace is located in Xinwu District, Wuxi City, covering an area of about 3,000 square meters, with R&D, production, quality control and other related functional areas, involving a variety of nuclides such as 177Lu, 89Zr, 90Y, 68Ga, and has introduced various advanced equipment to help R & D and production.
In the first half of 2023, Norroy successively ushered in many key nodes of development, the headquarters and R & D production center were successfully completed, the first industry-level nuclear drug industry forum was successfully held, A-round of financing was signed, and radioisotope workplace was officially opened. High frequency showed the speed and strength of Norroy.
Address: No.35-208, Changjiangnan Road, XinWu District, Wuxi, China
Mail address: bd@norroybioscience.com
Website: www.adm5.cn